00:00The Regnussi KD study is a study promoted by the Italian Society of Nephrology which has
00:05involved 30 nephrology centers distributed throughout the country and therefore there
00:11provides a snapshot of the management of chronic kidney disease in Italy. The team recruited
00:18more than 4,500 patients with chronic kidney disease not on dialysis and unfortunately the study
00:24a high rate of therapeutic inertia is highlighted, reaching 86 percent for inhibitors
00:34of the renin-angiotensin system at 91 percent for SGLT2 inhibitors when we consider
00:41patients who do not have diabetes and it even reaches 93 percent for GLP1 receptors
00:51Ragonis and 96 percent for the end of Renone when we consider patients who have
00:57chronic kidney disease associated with type 2 diabetes. It is clear that actions need to be taken
01:06to reduce this high rate of therapeutic inertia in specialist clinics
01:12nephrological fundamental is to create a collaboration network between hospital and territory that
01:20see involved general practitioner, nephrologist specialist but not only also diabetologist
01:27and cardiologist and then the other fundamental point is to make the use of renal tests
01:37filtrate and especially albuminuria routine tests because thanks to these tests we
01:43we stage kidney disease, we carefully stratify cardiovascular risk and
01:49we know if the therapies we have set up are working and we are on the right path
01:55This way we can guarantee kidney and cardioprotection to our patients.
